The 133.77 million shares were offloaded on average for 1,905 rupees, according to a statement from GlaxoSmithKline.

GSK brands like Horlicks, Boost, Maltova and Viva have come to HUL’s portfolio as part of the merger.

GSK, in a statement, said: “Using STEER’s state-of-the-art technology, high quality extruders, and dedicated personnel, the project has bro...

The company has received 99.99 per cent votes in favour of the scheme of amalgamation.

Unilever Plc’s India unit said on December 3 it would merge GSK Consumer with itself in an all-stock deal that will give it access to Horli...

GSK Consumer Healthcare said it will contest an attempt by Steer Engineering to block the transfer of technology that quickens the process ...

Tax officials could also raise the issue that GST of 12% is applicable on the overseas transaction.

Unilever edged past Nestle, the world’s largest food and drinks company, in a closely fought battle.

In response to recent press speculation, GSK confirms that consideration is being given to a potential transaction that includes a merger o...

Unilever’s purchase of GSK's unit, including Horlicks, comes as Indians lose their taste for sugary drinks.

Kellogg and Reckitt Benckiser are the latest entrants in the race to acquire the consumer nutrition biz.

As per Monday’s market value, 72 per cent of GSK is worth around Rs 17,980 crore.

Nestle, Unilever, PepsiCo may look to buy its nutrition business, but ITC ‘likely strong contender’ as malt-based brands can expand its por...

GSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.

The cross-functional collaboration deal, to swap select brands and independently market, sell and distribute them, is one of the four lever...

An inadvertent slip-up by a Nepali TV broadcaster has landed GlaxoSmithKline Consumer Healthcare’s (GSK) single-largest brand in India, Hor...

GSKCH managing director Zubair Ahmed shares how the company leveraged its pharma parentage, acquisition plans, etc.